Joe Lonsdale, a co-founder of Palantir, is investing in Primate Products, a company focused on breeding 30,000 monkeys for biomedical research. This initiative aims to establish a domestic supply chain for non-human primates in the United States, reducing reliance on imports, particularly from China. The monkeys will be used to study diseases such as Alzheimer's and Parkinson's, as well as autism, with funding support from entities like the United States National Institutes of Health. AI
RANK_REASON Significant investment in a company aiming to establish a domestic supply chain for research animals, impacting biomedical research infrastructure. [lever_c_demoted from significant: ic=1 ai=0.1]
- Alzheimer's disease
- autism
- China
- Florida
- Joe Lonsdale
- medical research
- monkeys
- Palantir
- Parkinson's disease
- Peter Thiel
- Primate Products
- United States National Institutes of Health
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →